by Tiana Tonrey | Mar 24, 2019 | Press Release, Press Releases
Vitro Biopharma 1st Quarter ended January 31st 2019 Financial Results of Operations Golden, Colorado-March 21, 2018-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st 2019 financial results of operations. Vitro...
by Tiana Tonrey | Mar 14, 2019 | Press Release, Press Releases
Golden, Colorado—March 12, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of provisional approval from the National Stem Cell Ethics Committee (NSCEC) of the Ministry of Health of the Commonwealth of the Bahamas for a clinical trial...
by Jim | Jan 24, 2019 | Press Release, Press Releases
Press Release Source: Vitro Diagnostics, Inc. Vitro Biopharma 2018 CEO Shareholder Letter:Record Revenues from Stem Cell Treatments Lead to 4th Quarter BreakevenCashflow & Growth...
by Joe McNierney | Dec 13, 2018 | Company News, Press Release
Golden, Colorado-December 12th, 2018-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma (“Vitro”) one of the world’s emerging biotechnology companies focused on Umbilical Cord Mesenchymal Stem Cell (“MSC”) research and clinical products has been awarded...
by Andrew Evans | Nov 20, 2018 | Press Release, Press Releases
Vitro BioPharma engages Senior Director of Sales and Marketing GOLDEN, CO/ACCESSWIRE/October 23,2018/Vitro Diagnostics, Inc. (OTC PINK: VODG), dba Vitro BioPharma today announced the engagement of a senior Sales and Marketing Director. The company has engaged Keith V....
by Tiana Tonrey | Sep 25, 2018 | Company News, Press Release
Vitro Biopharma 3rd Quarter 2018 Financial Results of Operations Golden, Colorado-September 24th, 2018-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro BioPharma, announced its 3rd quarter financial results of operations, ended July 31st, 2018. Vitro Diagnostics Inc....
